Additionally, the expression levels of MART-1, MAGE-A3 and PAX3 on CTCs have prognostic significance in patients with melanoma [20], and these proteins are highly expressed in melanoma tissues [21–25]. The gene discussed is MAGEA3; the disease is melanoma.